AbbVie
ABBV
#27
Rank
โ‚น31.994 T
Marketcap
โ‚น18,123
Share price
-1.76%
Change (1 day)
23.46%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

Earnings for AbbVie (ABBV)

Earnings in 2024 (TTM): โ‚น305.05 Billion

According to AbbVie's latest financial reports the company's current earnings are โ‚น56.33 Billion. a decrease over its 2023 earnings that were of โ‚น545.20 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AbbVie from 2011 to 2024

Annual earnings

Year Earnings Change
2024 โ‚น324.15 B-40.54%
2023 โ‚น545.20 B-53.62%
2022 โ‚น1.175 T3.76%
2021 โ‚น1.133 T282.25%
2020 โ‚น296.41 B-59.67%
2019 โ‚น735.01 B62.13%
2018 โ‚น453.34 B-32.74%
2017 โ‚น674.04 B-1.99%
2016 โ‚น687.73 B18.65%
2015 โ‚น579.65 B180.5%
2014 โ‚น206.65 B-55.57%
2013 โ‚น465.12 B-6.86%
2012 โ‚น499.39 B56.05%
2011 โ‚น320.01 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
โ‚น605.65 B 86.84%๐Ÿ‡บ๐Ÿ‡ธ USA
-โ‚น730.92 Billion-325.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.106 T 241.24%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น402.05 B 24.03%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น15.35 B-95.26%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น166.26 B-48.71%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น363.83 B 12.24%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น910.09 B 180.76%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น44.77 B-86.19%๐Ÿ‡บ๐Ÿ‡ธ USA